← FDA ENFORCEMENT
D-0607-2025Class III

Boothwyn Pharmacy LLC

Recalling firm
Boothwyn Pharmacy LLC
Product type
Drug
Status
Ongoing
Report date
2025-09-10
Distribution
U.S. Nationwide
Firm state
PA
Product quantity
8 vials
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Validation & Qualification
Reason for recall

Subpotent Drug

Product description

Fluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496

Code / lot info

06092025@23 BUD 09/09/2025

Other recalls SPEQ maps to Validation & Qualification
2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc
See all Validation & Qualification recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.